Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer: A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical Practice
Author:
Publisher
Elsevier BV
Subject
Urology
Reference26 articles.
1. European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study;Joniau;Eur Urol,2015
2. Emerging therapies in castration resistant prostate cancer;Thoreson;Can J Urol,2014
3. Characterising the castration-resistant prostate cancer population: a systematic review;Kirby;Int J Clin Pract,2011
4. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015;Gillessen;Ann Oncol,2015
5. Perspectives on treatment of metastatic castration-resistant prostate cancer;Merseburger;Oncologist,2013
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases;Scientific Reports;2023-05-29
2. Bone Scan Index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases;2023-03-01
3. Efficacy of cabazitaxel and androgen splicing variant-7 status in circulating tumor cells in Asian patients with metastatic castration-resistant prostate cancer;Scientific Reports;2022-10-26
4. Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography;Frontiers in Oncology;2021-11-19
5. Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study;International Journal of Urology;2021-06-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3